Scylla Premium Seamoss · 66-41 · SAINT LUCIA
For Scylla Premium Seamoss · 66-41 · SAINT LUCIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is SAINT LUCIA; product is Dried Sea Moss | Dried Sea Moss; product code is 24 T - - 29 Seaweed (Leaf & Stem Vegetable) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/08/2021; address is La - Pointe, Mon-Repos , Micoud, Vieux Fort SAINT LUCIA, verified against its source on 2026-09-16.
- Firm
- Scylla Premium Seamoss verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- SAINT LUCIA verified
- Address
- La - Pointe, Mon-Repos , Micoud, Vieux Fort SAINT LUCIA verified
- Date published
- 06/08/2021 verified
- Product code
- 24 T - - 29 Seaweed (Leaf & Stem Vegetable) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Dried Sea Moss | Dried Sea Moss each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product label includes drug/disease claims under ‘BENEFITS’: “Anti-Inflammatory” and “Relieves Respiratory Conditions” | The product appears to be an unapproved new drug as the product label includes drug/disease claims under ‘BENEFITS’: “Anti-Inflammatory” and “Relieves Respiratory Conditions” each item verified
What the source says
Scylla Premium Seamoss Date Published : 06/08/2021 La - Pointe, Mon-Repos , Micoud, Vieux Fort SAINT LUCIA 24 T - - 29 Seaweed (Leaf & Stem Vegetable) Date Published: 06/08/2021 Desc: Dried Sea Moss Notes: The product appears to be an unapproved new drug as the product label includes drug/disease claims under ‘BENEFITS’: “Anti-Inflammatory” and “Relieves Respiratory Conditions” 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/08/2021 Desc: Dried Sea Moss Notes: The product appears to be an unapproved new drug as the product label includes drug/disease claims under ‘BENEFITS’: “Anti-Inflammatory” and “Relieves Respiratory Conditions”
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.